Fred Hutch Cancer Center at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Fred Hutch Cancer Center brings 3 presentations to AMP 2026 in Seattle, its home city. Its sessions centre on residual disease detection and biomarker testing across blood and solid tumors. They cover high-color single-molecule PCR for monitoring blood cancers, Hi-C based testing that reveals genomic structure in lymphoma, lung cancer and sarcoma, and biomarker selection in genitourinary cancers.
| Organization | AMP 2026 Attendance |
|---|---|
Fred Hutch Cancer Center Seattle, WA | |
Cancer research center and treatment provider in Seattle, allied with UW Medicine. | Workshop Wed, Nov 11 12:00pm–12:50pm A New Detection Paradigm for Heme Oncology: High-Color Single-Molecule PCR for Reproducible MRD and Monitoring Single-molecule PCR across millions of partitions to count BCR::ABL1, KMT2A and other blood cancer variants reproducibly. Workshop Wed, Nov 11 2:00pm–2:50pm Aventa Clinical Testing Powered by Arima Hi-C: Revealing Actionable Genomic Structure Across Lymphoma, Lung Cancer, and Sarcoma Hi-C sequencing of FFPE tissue to map fusions and rearrangements in lymphoma, lung cancer and sarcoma cases. Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. |
Instantly find 20 buyers from Fred Hutch Cancer Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction